Article
PGF2α signaling drives fibrotic remodeling and fibroblast population dynamics in mice
7 Nov 2023
Abstract excerpt
Idiopathic pulmonary fibrosis (IPF) is a chronic parenchymal lung disease characterized by repetitive alveolar cell injury, myofibroblast proliferation, and excessive extracellular matrix deposition for which unmet need persists for effective therapeutics. The bioactive eicosanoid, prostaglandin F2α, and its cognate receptor FPr (Ptgfr) are implicated as a TGF-β1-independent signaling hub for IPF. To assess this,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
